亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

奧硝唑 CAS:16773-42-5

 
 
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 16773-42-5
過期 長期有效
更新 2020-06-18 10:08
 

隨州市紅旗化工有限公司

企業會員第15年
資料未認證
保證金未繳納
詳細說明
奧硝唑
CAS:16773-42-5
文別名 奧尼達唑;1-(3-氯-2-羥基丙基)-2-甲基-5-硝基咪唑
英文名稱:ornidazole
分子量:219.63
EC NO:240-826-0
分子式:C7H10ClN3O3
InChI:InChI=1/C7H10ClN3O3/c1-5-9-3-7(11(13)14)10(5)4-6(12)2-8/h3,6,12H,2,4H2,1H3
含量 99.0~101.0%
標準cp 2003 /USP24
性狀: 白色或微黃色粉末 熔點 85~90 ℃ 薄層檢測 合格 UV 最大吸收 :230nm ± 2nm, 312nm ± 2nm IR 符合標準 溶液顏色和澄清度 澄清,色澤不得深于 Z-3 重金屬 ≤ 20ppm 鐵鹽 ≤ 20ppm 氯化物 ≤ 0.02% 有關物質 ≤ 0.2% 干燥失重 ≤ 0.5% 禁發 硫酸灰分 ≤ 0.2%
 用途; 用作抗厭氧菌及抗原蟲藥
 包裝:25公斤/桶 
舉報收藏 0評論 0
更多>本企業其它產品
來氟米特 CAS號: 75706-12-6 頭孢曲松鈉 CAS;74578-69-1 福多斯坦 CAS號: 13189-98-5 克洛索隆 CAS;60200-06-8 磷酸吡哆醛 CAS號: 54-47-7 4-甲基噻唑-5-甲醛 CAS號: 82294-70-0 三氯苯噠唑 CAS:68786-66-3 5-乙酰水楊酸甲酯 CAS;16475-90-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |